Search results
European court rules drug kingpin Pablo Escobar’s name can’t be trademarked
Al Jazeera· 1 week agoThe name of Colombian drug lord Pablo Escobar cannot be registered as a European Union trademark for...
Democracy in Europe Election Farmers' Foment
The Daily Reflector· 1 week agoFILE - Polish farmers with national flags and angry slogans written on boards, protest against European Union green policies that trim ...
World Economy’s Great Escape Is No Comfort to the G-20
Bloomberg via Yahoo Finance· 2 weeks ago(Bloomberg) -- If the world economy is heading for a soft landing there’ll be plenty of anxiety...
US, Allies Press Hamas for ‘Immediate Release’ of Hostages
Bloomberg via Yahoo News· 2 days ago(Bloomberg) -- The US and 17 other nations pressed Hamas to release their citizens who are missing...
AP News in Brief at 12:04 a.m. EDT
Idaho State Journal· 5 days agoThe trial centers on allegations the former president falsified his company’s internal records to obscure the true nature of reimbursement payments to his former fixer and ...
Bitcoin-hating European Central Bank isn't doing much to stop scammers
The Cointelegraph· 3 days agoFTX co-founder Sam Bankman-Fried was sentenced to 25 years in jail. Apple co-founder Steve Wozniak just won an appeal against YouTube and the use of his likeness in promoting ...
World Leaders Urge Restraint as Israel Mulls Iran Response
Foreign Policy Magazine· 2 weeks agoWelcome back to World Brief, where we’re looking at what comes next in the Israel-Iran crisis,...
EU court rules 'Pablo Escobar' may not be registered as a trademark
dpa international via Yahoo News· 1 week agoThe name of the notorious Colombian drug lord Pablo Escobar may not be registered as a trademark for...
EU court says no trademark protection for drug kingpin Pablo Escobar
Courthouse News Service· 1 week agoThe General Court of the European Court of Justice denied an appeal from Roberto Escobar, the...
Vaccine Safety and DMT for Highly Active MS: New Data
Medscape· 3 days agoMany clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.